Principal Course Master:

Dr. Jarno Schmidt MRCVS, Dipl. ECVIM-CA (DE)

Course Masters:

Dr. Martin Kessler Dipl. ECVIM (Onc.) (DE)
Dr. Laurent Findji, Dipl. ECVS (UK)


Over the past decade, our knowledge of cancer in animals has increased rapidly. More and more veterinarians and clients are becoming open-minded about treating canine and feline cancer patients. “Oncology I” (2020) will start with the diagnostic approach to the cancer patient, including biopsy taking, staging procedures, diagnostic imaging options as well as several practical cytology sessions. Further, there will be a detailed discussion of the 3 main treatment options (surgery, radiation therapy, chemotherapy) and of novel cancer drugs (e.g. tyrosine kinase inhibitors (Palladia™, Masivet™), Stelfonta™, metronomic chemotherapy). Management of side effects will be explained and safe handling of chemotherapeutic drugs will be practiced hands-on.

“Oncology I” will address neoplasms of the skin and adnexal structures in detail as they are the most common tumours in clinical practice. A major emphasis of the course will be on interactive and case oriented work using a systematic approach to the cancer patient including recognizing symptoms, interpreting radiographic findings, choosing correct staging procedures and formulating a therapeutic plan.

“Oncology I” will start from scratch and provide a very solid basis of oncological principles and skin tumours. It is ideal for veterinarians with little or no previous knowledge in veterinary oncology, but also suitable for people, who want to deepen their understanding. This course includes both medical and surgical oncology (including surgical techniques) and is therefore ideal for candidates interested in either or both.

“Oncology II” and “Oncology III” will build up on this seminar and address all the remaining tumour systems in great detail. As in Oncology I, there will be a major focus on interactive case management and there will be a balance between both medical and surgical oncology.

Oncology I is mandatory before continuing on to the next courses. Oncology II and Oncology III can be taken in any order. Oncology IV can be taken only after completion of all Oncology modules.


• Tumour biology for clinicians
• Diagnostic imaging and tumour staging methods
• Biopsy techniques: theory and practice
• Tumour cytology: theory and practical sessions (microscopes)
• Paraneoplastic syndromes
• Understanding indications, limitations and risks involved with chemotherapy
• How to safely administer chemotherapy: this part includes a hands-on session introducing a safe and affordable system for administration of cytotoxic agents (PhaSeal™-system, Equashield™ system).
• Tyrosine Kinase Inhibitors Palladia™ and Masivet™: the first drugs approved by the European Medicines Agency (EMEA) for small animal tumours (canine mast cell tumours).
• How to use Stelfonta™ (Virbac) (EMEA licenced in 2020)
• Principles of surgical oncology including reconstruction in oncologic surgery
• Principles of radiation oncology
• Cutaneous neoplasms (incl. mast cell tumors, soft-tissue sarcoma, anal sac and perineal tumours, cutaneous digital tumours, etc)
• Interactive case management sessions

Topics Oncology I

• Basic tumour science
• Diagnostics
• Treatment options
• Paraneoplastic syndromes
• Skin tumours (the other tumour types will be covered in Oncology II and Oncology III)

Preliminary Program (Subject to change)

Friday, 6 November 2020
08:30 – 09:00 Welcome and registration
09:00 – 10:00 What is cancer? Current concepts of cancer biology and their implications for therapy
10:00 – 10:30 Basic tumour pathology
10:30 – 11:00 Coffee Break
11:00 – 12:30 Diagnostic approach to the cancer patient: understanding tumour “staging”
12:30 – 13:45 Lunch Break
Afternoon Small group work groups 1 and 2 rotating after the break
13:45 – 15:15 Group 1: Case management session: How do I biopsy this mass? Interactive session on techniques, problems and pitfalls in obtaining biopsies and reading pathology reports
Group 2: Paraneoplastic syndromes: case management
15:15 – 15:30 Coffee Break
15:30 – 17:00 groups 1 and 2 rotate
Saturday, 7 November 2020
09:00 – 09:45 Introduction to chemotherapy – how do these drugs work?
09:45 – 10:30 Chemotherapy drugs I Antitumour Antibiotics, Vinca-Alkaloids, Taxanes
10:30 – 11:00 Coffee Break
11:00 – 11:45 Chemotherapy drugs II Alkylating agents, L-Asparginase, Pred, Platinum-Drugs
11:45 – 12:30 How do I avoid and manage iatrogenic chemotherapy complications?
12:30 – 13:45 Lunch Break
Afternoon Small group work groups 1 and 2 rotating after the break
13:45 – 15:00 Group 1:
a. How to safely administer chemotherapy
b. Small group work (hand-on): how to use the PhaSeal™ & EquaShield™ Systems for safe application of chemotherapeutic agents
Group 2: How do I manage this chemotherapy side effect?
15:00 – 15:15 Coffee Break
15:15 – 16:30 groups 1 and 2 rotate
16:30 – 17:30 Facultative presentation: The AWARE Project
Sunday, 8 November 2020
09:00 – 09:45 Tips and tricks of how to perform fine-needle aspiration biopsies (incl. demonstration)
09:45 – 10:15 General approach to the skin tumour patient
10:15 – 10:45 Coffee Break
10:45 – 11:15 Benign skin tumours and tumour-like lesions
11:15 – 12:00 Feline squamous cell carcinomas (skin, nasal planum) and Bowen’s disease
12:00 – 12:30 Canine and feline cutaneous (& digital) melanomas
12:30 – 13:45 Lunch Break
13:45 – 15:00 Tumour cytology: getting started
15:00 – 17:00 groups 1 and 2 rotate on days 3 (p.m.) and day 4 (a.m.)
Group 1: Small group work: Practical tumour cytology I (including Coffee Break)
Group 2: Case-based approach to surgical oncology (including Coffee Break)
Monday, 9 November 2020
09:00 – 10:30 groups 1 and 2 rotate on days 3 (p.m.) and day 4 (a.m.)
Group 2: Small group work: Practical tumour cytology I
Group 1: Case-based approach to surgical oncology
10:30 – 11:00 Coffee Break
11:00 – 11:30 Basic principles of radiation oncology
11:30 – 12:00 “Metronomic chemotherapy: hype or hope”
12:00 – 13:00 Anal sac and perianal tumours
13:00 – 14:00 Lunch Break
14:00 – 17:15 Small group work: groups 1 and 2 rotating after the break
14:00 – 15:30 Group 1: Case management session Canine and feline soft-tissue sarcomas
Group 2: Practical tumour cytology II
15:30 – 15:45 Coffee Break
15:45 – 17:15 groups 1 and 2 rotate
Tuesday, 10 November 2020
08:00 – 08:30 Canine mast cell tumours: biology, diagnosis and general treatment options
08:30 – 09:30 Canine mast cell tumours: surgery
09:30 – 10:30 Stelfonta for the treatment of canine mast cell tumours
10:30 – 11:00 Coffee Break
11:00 – 11:45 Canine mast cell tumours: tyrosine kinase inhibitors and chemotherapy
11:45 –:12:15 Casus Case, Master vs Certificate Programme;
12:15 – 13:30 Lunch Break and hotel check out
13:30 – 14:15 Case management session. feline mast cell tumours
14:15 – 15:30 Case management session: Canine squamous cell carcinomas (digit, skin, nasal planum)
15:30 – 16:00 Wrap-up of the course and Q & A


Total hours: 40

ATF hours (Austria, Germany, Luxembourg, Switzerland): TBA

ECTS credits (Master & Certificate): 5


Registration and fees
Tuition fee: Euro 2.050.-
Course location
[et_pb_weather weather_location=”Frankfurt am Main, DE” use_icon=”on” icon_placement=”left” weather_unit=”metric” _builder_version=”4.6.1″ header_font=”Droid Sans||||” header_text_align=”left” header_text_color=”#000000″ header_font_size=”18″ header_font_size_tablet=”51″ header_line_height_tablet=”2″][/et_pb_weather]

Robert-Bosch-Straße 26, 63225 Langen (Hessen), Germany

Mercure Hotel Frankfurt Airport Langen: Robert-Bosch-Straße 26, 63225 Langen (Hessen), Germany
Mercure Hotel Frankfurt Airport Langen: Robert-Bosch-Straße 26, 63225 Langen (Hessen), Germany

Related courses

Course Date Registration Status
Oncologic Surgery: Head & Neck
Warsaw, Poland
05/03/2020 - 07/03/2020held
Oncology III
Luxembourg, Luxembourg
10/06/2020 - 14/06/2020postponed
Oncology II
Lisbon, Portugal
18/09/2020 - 22/09/2020postponed
Oncology IV
Lisbon, Portugal
23/09/2020 - 27/09/2020postponed
Oncology I
Frankfurt am Main, Germany
06/11/2020 - 10/11/2020cancelled